Biohaven Ltd.

EDGAR

24 filing records in this dataset, filed from 2022-10-18 to 2026-10-29. Reported financial figures are available; chart coverage varies by period.

Watchlist
Cash and cash equivalents
95.8 million USD Source
Exact value

95754000 USD

Long-term debt including current maturities
Not available
Shares outstanding
151 million shares Source
Exact value

151055160 shares

Reported share-count change

42.77% · 45.3 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 105803655 shares · 2025-09-30· Source
  • 151055160 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-543 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -738822000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -593267000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -130532000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -137311000 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -129279000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-473 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -609438000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -478776000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -149918000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -235017000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -149918000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -341868000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -235017000 USD · 2026-01-01 – 2026-06-30 Source

Capital expenditure

642 thousand USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Capital expenditure: 715000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 707000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 454000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 634000 USD · 2026-01-01 – 2026-09-30 Source
  • Capital expenditure: 454000 USD · 2026-01-01 – 2026-06-30 Source

Free cash flow

-473 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -609438000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -478776000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -149918000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -235017000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -149918000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -341868000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -235017000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 715000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 707000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 454000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 634000 USD · 2026-01-01 – 2026-09-30 Source
  • Capital expenditure: 454000 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-29.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 6 of 11 periods available· newest 2025-12-31
  • Net income: 6 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 6 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 6 of 11 periods available· newest 2025-12-31
  • Total assets: 5 of 11 periods available· newest 2025-12-31
  • Total liabilities: 5 of 11 periods available· newest 2025-12-31
  • Current assets: 5 of 11 periods available· newest 2025-12-31
  • Current liabilities: 5 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 5 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +USD 107.6 million

    Prior period

    −USD 846.42 million

    –

    Current period

    −USD 738.82 million

    –

    Exact inputs and evidence

    -738822000 − -846422000 = 107600000 USD

    -846422000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -738822000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 26.99 million

    Prior period

    −USD 582.45 million

    –

    Current period

    −USD 609.44 million

    –

    Exact inputs and evidence

    -609438000 − -582453000 = -26985000 USD

    -582453000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -609438000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -82.3%

    Prior period

    USD 4.05 million

    –

    Current period

    USD 715,000

    –

    Exact inputs and evidence

    715000 − 4049000 = -3334000 USD

    4049000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    715000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2020 2020-01-01 – 2020-12-31
−USD 118.67 million
Exact value

Exact value: -118668000 USD

2020-01-01 – 2020-12-31: -118668000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 75.96 million
Exact value

Exact value: -75957000 USD

2020-01-01 – 2020-12-31: -75957000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.1 million
Exact value

Exact value: 1097000 USD

2020-01-01 – 2020-12-31: 1097000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 77.05 million
Calculation and evidence

-75957000 − 1097000 USD

Exact free cash flow: -77054000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 213.8 million
Exact value

Exact value: -213796000 USD

2021-01-01 – 2021-12-31: -213796000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 145.84 million
Exact value

Exact value: -145840000 USD

2021-01-01 – 2021-12-31: -145840000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 938,000
Exact value

Exact value: 938000 USD

2021-01-01 – 2021-12-31: 938000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 146.78 million
Calculation and evidence

-145840000 − 938000 USD

Exact free cash flow: -146778000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 570.28 million
Exact value

Exact value: -570279000 USD

2022-01-01 – 2022-12-31: -570279000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 297.69 million
Exact value

Exact value: -297689000 USD

2022-01-01 – 2022-12-31: -297689000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 6.07 million
Exact value

Exact value: 6074000 USD

2022-01-01 – 2022-12-31: 6074000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 303.76 million
Calculation and evidence

-297689000 − 6074000 USD

Exact free cash flow: -303763000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 408.17 million
Exact value

Exact value: -408168000 USD

2023-01-01 – 2023-12-31: -408168000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 331.73 million
Exact value

Exact value: -331725000 USD

2023-01-01 – 2023-12-31: -331725000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.05 million
Exact value

Exact value: 3048000 USD

2023-01-01 – 2023-12-31: 3048000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 334.77 million
Calculation and evidence

-331725000 − 3048000 USD

Exact free cash flow: -334773000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 846.42 million
Exact value

Exact value: -846422000 USD

2024-01-01 – 2024-12-31: -846422000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 582.45 million
Exact value

Exact value: -582453000 USD

2024-01-01 – 2024-12-31: -582453000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.05 million
Exact value

Exact value: 4049000 USD

2024-01-01 – 2024-12-31: 4049000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 586.5 million
Calculation and evidence

-582453000 − 4049000 USD

Exact free cash flow: -586502000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 738.82 million
Exact value

Exact value: -738822000 USD

2025-01-01 – 2025-12-31: -738822000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 609.44 million
Exact value

Exact value: -609438000 USD

2025-01-01 – 2025-12-31: -609438000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 715,000
Exact value

Exact value: 715000 USD

2025-01-01 – 2025-12-31: 715000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 610.15 million
Calculation and evidence

-609438000 − 715000 USD

Exact free cash flow: -610153000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 1,366 latest values · 1,366 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001935979, 1935979, BHVN, edgar:1935979

Also known as Biohaven Ltd., Biohaven Research Ltd.